10991-1-AP
antibody from Proteintech Group
Targeting: FHL1
bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA
Antibody data
- Antibody Data
- Antigen structure
- References [28]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10991-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10991-1-AP, RRID:AB_2104230
- Product name
- FHL1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FHL1 antibody (Cat. #10991-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, zebrafish, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Zebrafish
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle.
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor.
Insulin-like growth factor receptor / mTOR signaling elevates global translation to accelerate zebrafish fin regenerative outgrowth.
Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients.
Disruption of the CCDC43-FHL1 interaction triggers apoptosis in gastric cancer cells.
Inhibition of Jumonji demethylases reprograms severe dilated cardiomyopathy and prolongs survival.
Downregulation of FHL1 protein in glioma inhibits tumor growth through PI3K/AKT signaling.
Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.
FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.
Hypoxia-induced alterations in the lung ubiquitin proteasome system during pulmonary hypertension pathogenesis.
Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.
Role of Zebrafish fhl1A in Satellite Cell and Skeletal Muscle Development.
A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity.
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers.
MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism.
FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.
The LIM domain protein FHL1C interacts with tight junction protein ZO-1 contributing to the epithelial-mesenchymal transition (EMT) of a breast adenocarcinoma cell line.
The LIM protein fhlA is essential for heart chamber development in zebrafish embryos.
Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma.
FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
Downregulation and growth inhibitory role of FHL1 in lung cancer.
FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeleton-associated proteins.
CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signaling.
Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.
Vahle B, Heilmann L, Schauer A, Augstein A, Jarabo MP, Barthel P, Mangner N, Labeit S, Bowen TS, Linke A, Adams V
International journal of molecular sciences 2024 Jun 16;25(12)
International journal of molecular sciences 2024 Jun 16;25(12)
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor.
Chen X, Yan Y, Liu Y, Yi Q, Xu Z
Journal of natural products 2024 Apr 26;87(4):837-848
Journal of natural products 2024 Apr 26;87(4):837-848
Insulin-like growth factor receptor / mTOR signaling elevates global translation to accelerate zebrafish fin regenerative outgrowth.
Lewis VM, Le Bleu HK, Henner AL, Markovic H, Robbins AE, Stewart S, Stankunas K
Developmental biology 2023 Oct;502:1-13
Developmental biology 2023 Oct;502:1-13
Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
Luo Q, Pan Y, Fu Q, Zhang X, Zhou S, Yu P, Tian H, Liu P, Chen S, Zhang H, Qin T
Cell biology and toxicology 2023 Oct;39(5):2069-2087
Cell biology and toxicology 2023 Oct;39(5):2069-2087
FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
Ng WH, Liu X, Ling ZL, Santos CNO, Magalhães LS, Kueh AJ, Herold MJ, Taylor A, Freitas JR, Koit S, Wang S, Lloyd AR, Teixeira MM, Merits A, Almeida RP, King NJC, Mahalingam S
Nature communications 2023 Oct 26;14(1):6605
Nature communications 2023 Oct 26;14(1):6605
Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients.
Lin Y, Ban R, Qiao L, Chen J, Liu M, Liu J, Shi Q
Journal of human genetics 2023 Jul;68(7):477-484
Journal of human genetics 2023 Jul;68(7):477-484
Disruption of the CCDC43-FHL1 interaction triggers apoptosis in gastric cancer cells.
Chen Y, Pei M, Li J, Wang Z, Liu S, Xiang L, Zhang J, Hong L, Lin J, Dai W, Xiao Y, Hu H, Tang W, Liu G, Yang Q, Lin Z, Jiang X, Wang Y, Wu X, Guo Z, Wang J
Experimental cell research 2022 Jun 1;415(1):113107
Experimental cell research 2022 Jun 1;415(1):113107
Inhibition of Jumonji demethylases reprograms severe dilated cardiomyopathy and prolongs survival.
Tran TA, Zhang QJ, Wang L, Gonzales C, Girard L, May H, Gillette T, Liu ZP, Martinez ED
The Journal of biological chemistry 2022 Feb;298(2):101515
The Journal of biological chemistry 2022 Feb;298(2):101515
Downregulation of FHL1 protein in glioma inhibits tumor growth through PI3K/AKT signaling.
Li SZ, Hu YY, Zhao JL, Zang J, Fei Z, Han H, Qin HY
Oncology letters 2020 Jun;19(6):3781-3788
Oncology letters 2020 Jun;19(6):3781-3788
Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.
Lukash T, Agback T, Dominguez F, Shiliaev N, Meshram C, Frolova EI, Agback P, Frolov I
Journal of virology 2020 Dec 9;95(1)
Journal of virology 2020 Dec 9;95(1)
FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.
Hu Z, Zhu Y, Liu X, Zhang W, Liu J, Wu S, Xiao J, Yuan Y, Wang Z
Journal of human genetics 2019 Sep;64(9):919-926
Journal of human genetics 2019 Sep;64(9):919-926
Hypoxia-induced alterations in the lung ubiquitin proteasome system during pulmonary hypertension pathogenesis.
Wade BE, Zhao J, Ma J, Hart CM, Sutliff RL
Pulmonary circulation 2018 Jul-Sep;8(3):2045894018788267
Pulmonary circulation 2018 Jul-Sep;8(3):2045894018788267
Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.
Wang X, Wei X, Yuan Y, Sun Q, Zhan J, Zhang J, Tang Y, Li F, Ding L, Ye Q, Zhang H
The Journal of cell biology 2018 Apr 2;217(4):1335-1351
The Journal of cell biology 2018 Apr 2;217(4):1335-1351
Role of Zebrafish fhl1A in Satellite Cell and Skeletal Muscle Development.
Chen F, Yuan W, Mo X, Zhuang J, Wang Y, Chen J, Jiang Z, Zhu X, Zeng Q, Wan Y, Li F, Shi Y, Cao L, Fan X, Luo S, Ye X, Chen Y, Dai G, Gao J, Wang X, Xie H, Zhu P, Li Y, Wu X
Current molecular medicine 2017;17(9):627-636
Current molecular medicine 2017;17(9):627-636
A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity.
Xu X, Fan Z, Liang C, Li L, Wang L, Liang Y, Wu J, Chang S, Yan Z, Lv Z, Fu J, Liu Y, Jin S, Wang T, Hong T, Dong Y, Ding L, Cheng L, Liu R, Fu S, Jiao S, Ye Q
Nature communications 2017 Jan 17;8:14059
Nature communications 2017 Jan 17;8:14059
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers.
Loft A, Forss I, Siersbæk MS, Schmidt SF, Larsen AS, Madsen JG, Pisani DF, Nielsen R, Aagaard MM, Mathison A, Neville MJ, Urrutia R, Karpe F, Amri EZ, Mandrup S
Genes & development 2015 Jan 1;29(1):7-22
Genes & development 2015 Jan 1;29(1):7-22
MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism.
Wang Y, Fu J, Jiang M, Zhang X, Cheng L, Xu X, Fan Z, Zhang J, Ye Q, Song H
PloS one 2014;9(10):e108708
PloS one 2014;9(10):e108708
FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.
Fu W, Wang K, Zhao JL, Yu HC, Li SZ, Lin Y, Liang L, Huang SY, Liang YM, Han H, Qin HY
BMC cancer 2014 Jun 22;14:463
BMC cancer 2014 Jun 22;14:463
The LIM domain protein FHL1C interacts with tight junction protein ZO-1 contributing to the epithelial-mesenchymal transition (EMT) of a breast adenocarcinoma cell line.
Zhao JL, Liang SQ, Fu W, Zhu BK, Li SZ, Han H, Qin HY
Gene 2014 Jun 1;542(2):182-9
Gene 2014 Jun 1;542(2):182-9
The LIM protein fhlA is essential for heart chamber development in zebrafish embryos.
Xie H, Fan X, Tang X, Wan Y, Chen F, Wang X, Wang Y, Li Y, Tang M, Liu D, Jiang Z, Liu X, Yuan W, Li G, Ye X, Zhou J, Mo X, Deng Y, Wu X
Current molecular medicine 2013 Jul;13(6):979-92
Current molecular medicine 2013 Jul;13(6):979-92
Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma.
Kashyap MK, Pawar HA, Keerthikumar S, Sharma J, Goel R, Mahmood R, Kumar MV, Kumar KV, Pandey A, Kumar RV, Prasad TS, Harsha HC
Cancer biomarkers : section A of Disease markers 2012-2013;12(1):1-9
Cancer biomarkers : section A of Disease markers 2012-2013;12(1):1-9
FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
Lin J, Qin X, Zhu Z, Mu J, Zhu L, Wu K, Jiao H, Xu X, Ye Q
IUBMB life 2012 Nov;64(11):921-30
IUBMB life 2012 Nov;64(11):921-30
Downregulation and growth inhibitory role of FHL1 in lung cancer.
Niu C, Liang C, Guo J, Cheng L, Zhang H, Qin X, Zhang Q, Ding L, Yuan B, Xu X, Li J, Lin J, Ye Q
International journal of cancer 2012 Jun 1;130(11):2549-56
International journal of cancer 2012 Jun 1;130(11):2549-56
FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
Ding L, Niu C, Zheng Y, Xiong Z, Liu Y, Lin J, Sun H, Huang K, Yang W, Li X, Ye Q
Journal of cellular and molecular medicine 2011 Jan;15(1):72-85
Journal of cellular and molecular medicine 2011 Jan;15(1):72-85
MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeleton-associated proteins.
Leitner L, Shaposhnikov D, Mengel A, Descot A, Julien S, Hoffmann R, Posern G
Journal of cell science 2011 Dec 15;124(Pt 24):4318-31
Journal of cell science 2011 Dec 15;124(Pt 24):4318-31
CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
Matsumoto M, Kawakami K, Enokida H, Toki K, Matsuda R, Chiyomaru T, Nishiyama K, Kawahara K, Seki N, Nakagawa M
International journal of molecular medicine 2010 Aug;26(2):241-7
International journal of molecular medicine 2010 Aug;26(2):241-7
Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signaling.
Lin J, Ding L, Jin R, Zhang H, Cheng L, Qin X, Chai J, Ye Q
The international journal of biochemistry & cell biology 2009 Jul;41(7):1613-8
The international journal of biochemistry & cell biology 2009 Jul;41(7):1613-8
Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.
Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu W, Zhu J, Han J, Zhang H, Lin J, Cheng L, Qin X, Niu C, Yuan B, Wang X, Zhu C, Zhou Y, Li J, Song H, Huang C, Ye Q
The Journal of clinical investigation 2009 Feb;119(2):349-61
The Journal of clinical investigation 2009 Feb;119(2):349-61
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 10991-1-AP(FHL1 antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FHL1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human FHL1. This antibody recognizes human, mouse, rat antigen. The FHL1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.